Oxford Biomedica (OXB) News Today → [FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks (From Crypto 101 Media) (Ad) Free OXB Stock Alerts GBX 331 +10.50 (+3.28%) (As of 05/31/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesInsider TradesStock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesInsider Trades All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 28, 2024 | finance.yahoo.comOxford Biomedica (LON:OXB) investors are sitting on a loss of 71% if they invested three years agoMay 28, 2024 | finance.yahoo.comOxford Biomedica (LON:OXB) investors are sitting on a loss of 71% if they invested three years agoMay 23, 2024 | lse.co.ukOxford Biomedica Share ChatMay 21, 2024 | marketbeat.comOxford Biomedica (LON:OXB) Given Outperform Rating at Royal Bank of CanadaRoyal Bank of Canada restated an "outperform" rating and set a GBX 740 ($9.41) price target on shares of Oxford Biomedica in a report on Tuesday.March 5, 2024 | finanznachrichten.deOxford BioMedica plc: Update to Medium-Term Financial Guidance and 2023 Trading and Notice of Preliminary ResultsMarch 5, 2024 | finance.yahoo.comUpdate to Medium-Term Financial Guidance and 2023 Trading and Notice of Preliminary ResultsFebruary 10, 2024 | marketbeat.comOxford Biomedica (LON:OXB) Share Price Crosses Below Two Hundred Day Moving Average of $251.96Oxford Biomedica (LON:OXB) Stock Price Passes Below 200-Day Moving Average of $251.96February 5, 2024 | lse.co.ukEnSilica hires new chief financial officer from Oxford BiomedicaFebruary 2, 2024 | marketbeat.comOxford Biomedica (LON:OXB) Shares Pass Below Two Hundred Day Moving Average of $263.21Oxford Biomedica (LON:OXB) Stock Price Crosses Below 200 Day Moving Average of $263.21January 29, 2024 | finance.yahoo.comOxford Biomedica completes acquisition of ABL EuropeDecember 19, 2023 | finance.yahoo.comOxford Biomedica (LON:OXB) shareholders have endured a 79% loss from investing in the stock three years agoDecember 4, 2023 | msn.comOxford Biomedica inks deal to provide ‘footprint’ in EU marketDecember 4, 2023 | finance.yahoo.comOxford Biomedica signs agreement to acquire ABL Europe from Institut Mérieux, consolidating position as a global pure-play CDMOOctober 22, 2023 | finance.yahoo.comOxford Biomedica's UK£39m Market Cap Fall Books Insider LossesSeptember 22, 2023 | finance.yahoo.comOxford Biomedica First Half 2023 Earnings: Misses ExpectationsSeptember 20, 2023 | finance.yahoo.comOxford BioMedica shares soar as vaccine maker raises earnings guidanceJuly 18, 2023 | finance.yahoo.comOxford Biomedica Implements Sapio Sciences' Electronic Laboratory NotebookMay 25, 2023 | msn.comRBC Capital Markets Reiterates Oxford Biomedica (LSE:OXB) Outperform RecommendationMay 15, 2023 | finance.yahoo.comOxford Biomedica launches TetraVecta - the next generation lentiviral vector systemMay 5, 2023 | finance.yahoo.comWhy Investors Shouldn't Be Surprised By Oxford Biomedica plc's (LON:OXB) Low P/SApril 26, 2023 | finance.yahoo.comOxford Biomedica Appoints Leone Patterson as Non-Executive DirectorApril 25, 2023 | markets.businessinsider.comOxford Biomedica Posts FY LossApril 21, 2023 | marketwatch.com2023-2030 "CGT CDMO Market" Share | Global Industry Analysis and ForecastApril 12, 2023 | marketwatch.com2023-2030 Global CGT CDMO Market is Growing Rapidly with Modern TrendMarch 26, 2023 | marketwatch.comCGT CDMO Market Share and Forecast till 2030March 15, 2023 | benzinga.comOxford BioMedica Stock (OTC:OXBDF), Quotes and News SummaryMarch 11, 2023 | finance.yahoo.comAs Oxford Biomedica plc's market cap (LON:OXB) drops to UK£484m, insiders might be questioning their decision to buy earlier this yearFebruary 25, 2023 | marketwatch.comWhat is a CAGR of CGT CDMO Market? CGT CDMO Market Value in 2028 with Competition Analysis Data of Top Key PlayersFebruary 22, 2023 | marketwatch.comCGT CDMO Market Size Global Research Report, 2023 - 2028January 30, 2023 | marketwatch.comCGT CDMO Market Size 2023 Trend and Opportunities, Analysis, CAGR and Value Chain Study, Business Growth to 2028January 20, 2023 | marketwatch.comCGT CDMO Market Provides an In-Depth Insight of Trends and Landscape Outlook 2023-2028January 12, 2023 | marketwatch.comCGT CDMO Market Present Development Scenario and Growth Prospects to help you understand the Implications for Your Business | Newest 112 InsightsJanuary 1, 2023 | finance.yahoo.comA Look At The Intrinsic Value Of Oxford Biomedica plc (LON:OXB)December 14, 2022 | yahoo.comOxford Biomedica Solutions forms new partnerships with three biotechnology companiesDecember 9, 2022 | marketwatch.comCGT CDMO Market 2022 : Incredible Possibilities, Growth Analysis and Forecast To 2028November 22, 2022 | finance.yahoo.comOxford Biomedica Appoints Dr Frank Mathias as Chief Executive OfficerOctober 25, 2022 | marketwatch.comCGT CDMO Market Size 2022 Is Changing Consumer Habits, this Industry in the Globe Has Noticed Substantial Growth to 2028 | 112 Pages ReportOctober 7, 2022 | finance.yahoo.comAmendment of Short-Term Loan Facility into new Term Loan Facility With OaktreeSeptember 29, 2022 | finance.yahoo.comBullish Oxford Biomedica plc (LON:OXB) insiders filled their treasuries with UK£658k worth of stock over last yearSeptember 15, 2022 | finance.yahoo.comEdited Transcript of OXB.L earnings conference call or presentation 15-Sep-22 12:00pm GMTSeptember 15, 2022 | uk.finance.yahoo.comFTSE: Oxford Biomedica sees revenue drop as COVID vaccine demand dropsSeptember 14, 2022 | finance.yahoo.comOxford Biomedica Solutions signs agreement with new partner to deliver The Full Solution for their AAV programsSeptember 12, 2022 | finance.yahoo.comOxford Biomedica plc (OXB.L)July 1, 2022 | msn.comOxford Biomedica signs new deal to make AstraZeneca COVID shotJuly 1, 2022 | finance.yahoo.comOxford Biomedica Inks New Three Year Deal To Make AstraZeneca's COVID-19 VaccineJuly 1, 2022 | msn.comOxford Biomedica extends deal with AstraZeneca to make Covid vaccines on an as-needed basisJuly 1, 2022 | nasdaq.comOxford Biomedica, AstraZeneca Extend COVID-19 Vaccine Manufacturing PartnershipJune 14, 2022 | nasdaq.comOxford Biomedica: FDA Lifts Clinical Hold On Homology Medicines' PheNIX TrialMarch 11, 2022 | finance.yahoo.comOxford Biomedica broadens its viral vector capabilities with the launch of Oxford Biomedica Solutions, a full scope AAV business in Boston, following closing of its deal with HomologyJanuary 28, 2022 | tmcnet.comOxford Biomedica broadens leading viral vector offerings by Get Oxford Biomedica News Delivered to You Automatically Sign up to receive the latest news and ratings for OXB and its competitors with MarketBeat's FREE daily newsletter. Email Address Dems have chosen Biden replacement? (Ad)On November 16, 2023… Joe Biden accidentally revealed the name of the candidate… Who will replace him in the 2024 presidential election. See who it is HERE. OXB Media Mentions By Week OXB Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. OXB News Sentiment▼1.290.77▲Average Medical News Sentiment OXB News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. OXB Articles This Week▼20▲OXB Articles Average Week Get Oxford Biomedica News Delivered to You Automatically Sign up to receive the latest news and ratings for OXB and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Genus News Oxford Nanopore Technologies News Ergomed News PureTech Health News Bioventix News Arix Bioscience News hVIVO News Avacta Group News Faron Pharmaceuticals Oy News Futura Medical News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (LON:OXB) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProBiden replacement revealed?Paradigm PressWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersHe Is Giving Away BitcoinCrypto Swap ProfitsThe #1 Crypto That You Don’t Own… YetCrypto 101 MediaHow Biden has already won 2024Porter & CompanyThis unknown company solves the biggest issue with AIManward Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oxford Biomedica plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
